HIV testing and consent in Florida underwriting
Florida regulates HIV testing in insurance underwriting more tightly than most states, and s. 627.429, F.S., is written as a series of narrow permissions rather than broad ones. Almost every wrong answer on this topic is something an insurer may plausibly want to do and is specifically forbidden from doing.
| Before any test | The insurer must disclose its intent to test and obtain written informed consent (s. 627.429, F.S.) |
| What the consent must explain | The test, its purpose, potential uses, limitations, and the meaning of its results — a signature on a blank or generic authorization does not satisfy this |
| What the application may ask | Only whether the person has TESTED POSITIVE for exposure to HIV, or has been DIAGNOSED with AIDS or AIDS-related complex. Broader questions about risk, exposure or lifestyle are not permitted |
| What may never determine who is tested | Sexual orientation. The statute also bars marital status, living arrangements, occupation, gender, beneficiary designation and ZIP code from being used for that purpose |
| Before an adverse decision | Written informed consent must have been obtained AND the testing must follow the applicable CDC- or FDA-recommended protocol, including any recommended confirmatory test — a single positive screen is not enough |
| Cancellation and nonrenewal | No insurer may cancel or nonrenew a health policy because of the diagnosis or treatment of HIV infection or AIDS, notwithstanding any other law (s. 627.6265, F.S.) |
| Where HIPAA sits alongside this | Obtaining protected health information from the applicant's physicians requires a separate specific signed HIPAA authorization naming the information, the recipients, an expiration, and the right to revoke |
Where the point is lost: The pattern to carry into the exam: consent first, narrow questions only, protocol before any adverse decision, and diagnosis alone can never end an existing health policy. When an option describes an insurer inferring who to test from how someone lives, it is wrong.
HIV testing and consent in Florida underwriting
10 questions on Florida HIV testing insurance underwriting, each with an explanation and statute citation.
10 questions
Pass line: 70%, same as the real exam
Questions and answers, explained
All 10 questions above, with the correct answer and why it is correct. Everything here is on hiv testing and consent in florida underwriting.
While selling a health insurance policy, an agent tells the applicant that an accidental death rider is "required by Florida law" and charges for it without the applicant's informed consent. The rider is not actually required by law. The agent has committed:
Why: Sliding includes representing that a coverage is required by law when it is not, representing that ancillary coverage is included at no extra charge when a charge applies, or charging for ancillary coverage without the applicant's informed consent (s. 626.9541(1)(z), F.S.). Coercion — the closest distractor — involves boycott, intimidation, or restraint to force insurance transactions, not deceptively attaching extra products to a sale. (Outline FL-I.I)
Reference s. 626.9541(1)(z), F.S. — Outline FL-I.I
Before an insurer may test a Florida insurance applicant for HIV, s. 627.429, F.S., requires the insurer to:
Why: Section 627.429, F.S., requires the insurer to disclose its intent to test for HIV and obtain written informed consent that fairly explains the test, its purpose, potential uses, limitations, the meaning of results, and the right to confidential treatment. A positive result must be reported to a physician designated by the applicant or, absent a designation, to the Department of Health — not casually disclosed; verbal consent or burying the test in routine blood work does not satisfy the statute.
Reference FL-III.H; s. 627.429, F.S.
Before an insurer may obtain an applicant's protected health information from her physicians, HIPAA requires
Why: HIPAA's privacy rule requires a specific signed authorization with defined content — the information covered, the permitted recipients, an expiration date or event, and notice of the right to revoke — before a covered provider may release protected health information to an insurer. A general signature on the application is not sufficient; the authorization is a separate document the applicant signs and normally receives a copy of, and it is a distinct requirement from the separate written informed consent Florida requires before HIV testing under s. 627.429, F.S.
Reference Outline IX (Field Underwriting Procedures): HIPAA privacy and insurability information; s. 627.429, F.S.
A Florida life insurer's HIV test on an applicant comes back positive. Under s. 627.429, F.S., how must that result be communicated to the applicant?
Why: s. 627.429, F.S., requires that a positive HIV result be delivered through a physician chosen by the applicant or through the Department of Health, accompanied by face-to-face counseling covering the meaning of the result, the possible need for further testing, and how to prevent transmission. Choice D fails on both counts: the insurer may neither mail the result directly nor skip the counseling requirement.
Reference s. 627.429, F.S. — HIV testing: notification and counseling
As part of underwriting, a life insurer wants a Florida applicant to be tested for HIV. Before the test may be administered, the insurer must:
Why: Section 627.429, F.S., requires that before HIV testing, the insurer disclose its intent to test and obtain the applicant's written informed consent, including a fair explanation of the test, its purpose, potential uses, the meaning of results, and the right to confidential treatment of the information. Verbal consent (the closest distractor) does not satisfy the statute — the consent must be written. Outline III.A (disclosures at point of sale — HIV consent).
Reference Outline III.A — Disclosures at point of sale (HIV consent); s. 627.429, F.S.
Under s. 627.429, F.S., an application for life or health insurance in Florida may ask an applicant:
Why: Section 627.429, F.S., permits questions limited to whether the person has tested POSITIVE for exposure to HIV infection or has been diagnosed as having AIDS or AIDS-related complex. Option A is the closest distractor and is not allowed: asking whether someone has been tested, or about negative results (D), would penalize responsible testing and is outside the permitted inquiry. Questions about other household members (C) have no bearing on the applicant's own insurability.
Reference FL-III.H; s. 627.429, F.S.
Under Florida's HIV testing statute, an insurer that tests a life insurance applicant for HIV may do all of the following EXCEPT:
Why: s. 627.429, F.S., imposes strict confidentiality: results may be shared inside the company and with affiliates, agents, and reinsurers, but may not be furnished to industry information data banks in any form that identifies the individual. Choice A is permitted because testing thresholds tied to the amount of coverage and applied to an entire class are allowed; what is never allowed is using sexual orientation to select who is tested or to make an underwriting decision.
Reference s. 627.429, F.S. — confidentiality of HIV test results
An underwriter proposes requiring an HIV test for every male applicant who is unmarried, lives with a same-sex roommate, and names a nonrelative as beneficiary. Under s. 627.429, F.S., this practice is:
Why: Section 627.429, F.S., bars an insurer from using sexual orientation in underwriting or in determining whom to test, and expressly bars using marital status, living arrangements, occupation, gender, beneficiary designation, ZIP code, or other territorial classification to establish an applicant's sexual orientation. Option B is the closest distractor and fails because consistency cannot cure a criterion that is itself unlawful; the violation occurs when the testing rule is applied, not only upon denial (D).
Reference FL-III.H; s. 627.429, F.S.
An applicant's initial HIV screening test is positive. Before making an adverse underwriting decision on that basis, s. 627.429, F.S., requires the insurer to:
Why: Under s. 627.429, F.S., an adverse underwriting decision may rest on HIV test results only when written informed consent was obtained and the testing follows the applicable CDC- or FDA-recommended protocol, including any recommended follow-up confirmatory test. Positive results must be communicated through a physician the applicant designates, or to the Department of Health, with counseling. Option C is not merely unnecessary — furnishing identifiable HIV results to an industry data bank is prohibited.
Reference FL-III.H; s. 627.429, F.S.
Under s. 627.6265, F.S., a Florida health insurer may NOT cancel or nonrenew an insured's policy because of:
Why: Notwithstanding any other law, no insurer may cancel or nonrenew the health insurance policy of any insured because of the diagnosis or treatment of human immunodeficiency virus infection or acquired immune deficiency syndrome (s. 627.6265, F.S.). The other three are legitimate grounds recognized elsewhere in the code, chiefly in the individual renewability statute, s. 627.6425, F.S. Do not confuse this rule with s. 627.429, F.S., which governs the informed-consent and confidentiality requirements an insurer must satisfy BEFORE it may HIV-test an applicant.
Reference FL-III.H; s. 627.6265, F.S.
Drill the whole domain
- Florida Statutes and Rules — Common to All Lines (13%)
- Florida Statutes — Health Insurance (10%)
- Florida Statutes — Life and Annuity (incl. Variable Products) (10%)
Other topics
- Free look periods on the Florida 2-15
- Twisting vs churning vs sliding vs rebating
- Annuities on the Florida 2-15
- Medicare and Medicare supplement rules
- Life policy provisions and clauses
- Disability income insurance
- Variable life, VUL and the separate account
- Annuity best interest rules for buyers 65+
- Premium trust funds and fiduciary duty
- Compulsory vs discretionary license discipline
- Buyer's Guide and Florida free look periods
- Florida guaranty association limits
- License, appointment and continuing education